À compter du 1er décembre 2023, l’accès à POEMs et à Essential Evidence Plus ne fera plus partie des avantages offerts aux membres de l’AMC.
Question clinique
What changes in vaginal bleeding can women expect after the placement of a levonorgestrel intrauterine system?
L’Essentiel
Bleeding decreased over time for most women after the insertion of a levonorgestrel intrauterine system (LNG-IUS). Bleeding or spotting requiring the use of sanitary products occurred for a mean of 36 of the first 90 days after insertion and then decreased markedly for most women (to means of 19, 14, and 12 days in the 3 succeeding 90-day periods, respectively). Days of frank bleeding were fewer, on average, with means of 13, 8, 6, and 5 days in each of the four 90-day periods after insertion. 2a
Référence
Plan de l'etude: Meta-analysis (other)
Financement: Government
Cadre: Outpatient (specialty)
Sommaire
The authors of this systematic review and meta-analysis conducted it for the stated purpose of providing information to help clinicians counsel patients about what to expect regarding vaginal bleeding after the placement of a LNG-IUS. The authors identified 7 studies—4 randomized controlled trials (RCTs), 2 cohort studies, and 1 re-analysis of RCT data—that met their inclusion criteria with a total of 5098 participants from 10 countries. Included studies reported outcomes of interest for women with a history of normal menstrual periods for at least 90 days after the placement of LNG-IUS (52 mg; Mirena or Liletta) according to bleeding diaries. Bleeding outcomes were the number of bleeding and/or spotting days based on World Health Organization definitions. The authors excluded studies if the study population was women with heavy or prolonged menstrual periods, who were actively breastfeeding, who used long-acting contraception methods within 6 months prior to placement, or who had anatomic pathologies (such as fibroids or cancer). The authors extracted mean or median days of bleeding only, spotting only, and bleeding and/or spotting in 90-day intervals for the year after placement. They found that bleeding decreased markedly after the first 90-day interval. For bleeding and/or spotting, the results over succeeding periods were 35.6 days (95% CI 32.2 - 39.1), 19.1 days (16.1 - 21.5), 14.2 days (11.7 - 16.8), and 11.7 days (9.7 - 13.7). The results for bleeding-only days were 13.3 days (10.8 - 15.7), 7.8 days (6.5 - 9.1), 6.2 days (4.9 - 7.5), and 5.0 days (3.9 - 6.1), respectively, for the four 90-day periods. The authors conducted several sensitivity analyses to account for heterogeneity between studies, which did not materially change the findings.
Reviewer
Linda Speer, MD
Professor and Chair, Department of Family Medicine
University of Toledo
Toledo, OH